Dear Colleagues

On behalf of the Viral Hepatitis Congress Scientific Committee, we are delighted to announce that the 2014 Viral Hepatitis Congress will take place at the Sheraton Frankfurt Airport Hotel & Conference Center, Frankfurt, Germany, from 9–11 October 2014.

In 2013, we once again produced a high-quality and relevant scientific programme, augmented by extremely popular, innovative and interactive discussion sessions. We are confident that, by continuing to invite a world-class faculty, this year will be even better.

2014 will see great changes in the field of viral hepatitis, with many drugs arriving and various treatment options for our patients. In this rapidly evolving environment, it is more important than ever to sustain a forum where the wealth of data can be put into a practical perspective for our colleagues.

The Viral Hepatitis Congress will digest the latest data from a broad range of sources, examine the new treatments, and translate this array of information for our audience. We are bringing together a cutting-edge programme, which will explore the clinical challenges presented by viral hepatitis infection and its associated complications.

We spoke with a number of people at  the 2013 Congress who praised the intimate nature of the meeting, which allows excellent opportunities for networking. We are keen to retain this friendly atmosphere as we examine a range of topics over two-and-a-half days, with the unprecedented level of interaction provided by the state-of-the-art keypads, which we introduced at the 2013 Congress.

We look forward to seeing you in Frankfurt in October.

Yours sincerely

Professor Ira Jacobson and Professor Stefan Zeuzem
Co-Chairs of the Viral Hepatitis Congress

Participants in the meeting will be able book accommodation through the Organising Secretariat, more information will be available shortly.

At the same time as the Congress, Frankfurt will host its annual Book Fair, this means that accommodation will be in very short supply, therefore we recommend participants book early to avoid disappointment.

Submission Info

Abstract categories

Abstract categories for 2014 are as follows:
Hepatitis C Virus
Diagnosis
Natural history and epidemiology
Treatment and late-stage clinical trials (Phase IIb, Phase III and Phase IV)
Practical management strategies
Treatment monitoring and predictors of therapeutic response
Preclinical and early clinical development (Phase I and Phase IIa)
Direct-acting antiviral combinations
Molecular biology and characterisation
Other
Hepatitis B Virus
Diagnosis and monitoring
Natural history and epidemiology
Treatment and late-stage clinical trials (Phase IIb, Phase III and Phase IV)
Practical management strategies
Preclinical and early clinical development (Phase I and Phase IIa)
Molecular biology and characterisation
Other
Hepatocellular Carcinoma
Diagnosis, natural history and epidemiology
Clinical trials
Practical management strategies
Molecular biology and characterisation
Other
Pharmacokinetics and drug interactions
HIV co-infection and viral hepatitis
Transplantation and viral hepatitis
Viral Hepatitis A, D and E

Back to top

Oral & Poster presentations

If the submitted abstract is accepted for presentation at the Congress, it will be as either an Oral or a Poster:

• Oral presentations: 15 minutes slots within the scientific sessions (10 minutes, plus five for questions), to present your work in the main auditorium to the other participants at the Congress.
• Poster presentations: present your work to the other participants from a poster alongside the exhibition, at dedicated sessions throughout the Congress programme.

Abstracts are more likely to be considered for an Oral presentation (as opposed to a Poster) if they contain new information and clinical rather than non clinical data.

Back to top

Submission guidelines

Please consider the following guidelines when submitting your abstract:

• Authors
  • Where the submitting author and presenting author are different, please include email addresses for both.
  • Where family name and initials are requested, the initials are for the given names only (not the family name). For example, John Andrew Smith, the family name is Smith and the initials are J A.
• Abstract
  • Your abstract should not exceed 2500 characters (including spaces)
  • Structured (with headings) and unstructured (without headings) abstracts are accepted, however where headings are included, please use the following style, where possible:

PURPOSE OF THE STUDY: Text run on, on the same line, regular font (not bold)
METHOD: Text run on, on the same line, regular font (not bold)
SUMMARY OF RESULTS: Text run on, on the same line, regular font (not bold)
CONCLUSION: Text run on, on the same line, regular font (not bold)

• References
  • The reference style is Vancouver (numbered). References must be numbered consecutively and cited in the text using arabic numerals within parentheses.
  • List all authors when six or fewer; when seven or more, list only the first three and add et al.

Back to top

Scholarships for junior researchers

The Scientific Committee is pleased to confirm that funds have been allocated towards assisting the attendance of junior researchers. To qualify for a scholarship, researchers must be 35 years or under at the time of the Congress and submit an abstract which will be reviewed alongside all other submitted abstracts.
Authors have the opportunity to indicate that they wish to be considered for a scholarship by checking the appropriate box at the time of submission.

Back to top

Late Breaker abstracts

Anyone wishing to submit a Late Breaker abstract should send a letter of intent to the Organising Secretariatby Tuesday 8 July addressed to Professor Stefan Zeuzem or Professor Ira Jacobson, Chairs of the Scientific Committee. The deadline date for receipt of Late Breakers is Tuesday 29 July.

Back to top

Notification of review process

You will be notified by Friday 1 August of the outcome of your submission. If you have not received an email by Monday 11 August please contact the Organising Secretariat.

If you have any questions or queries about the Viral Hepatitis Congress, the Organising Secretariat are always happy to help.

The Viral Hepatitis Congress
Organising Secretariat
KnowledgePoint360 Group
Victoria Mill, Windmill Street
Macclesfield
SK11 7HQ, UK

t: +44 (0) 1625 664392
f: +44 (0) 1625 664391
e: hep@kp360group.com